Combinations of TLR ligands: a promising approach in cancer immunotherapy.
about
The Role of Toll-Like Receptors in Hematopoietic MalignanciesHRG/HER2/HER3 signaling promotes AhR-mediated Memo-1 expression and migration in colorectal cancer.Targeting Innate Immunity with dsRNA-Conjugated Mesoporous Silica Nanoparticles Promotes Antitumor Effects on Breast Cancer Cells.Modulating the innate immune activity in murine tumor microenvironment by a combination of inducer molecules attached to microparticles.Abdominal Wall Reconstruction after Flap Surgery and the Effect on the Immune System.Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.
P2860
Combinations of TLR ligands: a promising approach in cancer immunotherapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Combinations of TLR ligands: a promising approach in cancer immunotherapy.
@en
Combinations of TLR ligands: a promising approach in cancer immunotherapy.
@nl
type
label
Combinations of TLR ligands: a promising approach in cancer immunotherapy.
@en
Combinations of TLR ligands: a promising approach in cancer immunotherapy.
@nl
prefLabel
Combinations of TLR ligands: a promising approach in cancer immunotherapy.
@en
Combinations of TLR ligands: a promising approach in cancer immunotherapy.
@nl
P2093
P2860
P356
P1476
Combinations of TLR ligands: a promising approach in cancer immunotherapy.
@en
P2093
Claudia Maletzki
Michael Linnebacher
Saskia Stier
Ulrike Klier
P2860
P304
P356
10.1155/2013/271246
P577
2013-11-25T00:00:00Z